Table 1 Pre-HSCT evaluation in patients with mucopolysaccharidosis type I-H.
Age at diagnosis in months (median, IQR), n = 49 | 10 (7–14) | Brain MRI abnormalities (n, %) | |
---|---|---|---|
Sex ratio F:M, n = 51 | 2: 3 | Lateral ventricles enlargementb | 20/40 (50%) |
Clinical features (n, %) | WMH or delayed myelination | 21/40 (53%) | |
Typical coarse facial features | 47/47 (100%) | Virchow - Robin spaces enlargement | 28/35 (80%) |
Macrocrania | 34/43 (79%) | IDUA gene molecular analysis (n, %), n = 102 alleles | |
Thoracolumbar kyphosis | 41/44 (93%) | p.Trp402* allele | 57/102 (56%) |
Airway obstructiona | 38/41 (93%) | p.Gln70* allele | 11/102 (11%) |
Umbilical or inguinal hernia | 23/41 (56%) | Other nonsense allelesc | 5/102 (5%) |
Hepatomegaly | 37/42 (88%) | Indels or splicing allelesc | 11/102 (11%) |
Splenomegaly | 17/42 (40%) | Missense allelesc | 13/102 (12%) |
Corneal clouding | 29/41 (71%) | Other allelesc (non p.Trp402*/non p.Gln70*) | 5/102 (5%) |
Active hydrocephalus and/or VP shuntb | 9/51 (18%) |